Research and Analysis Techniques for Eli Lilly Challenges

This presentation explores Eli Lilly's strategic focus, starting with a $4.5B Medicine Foundry aimed at addressing key challenges in drug development and research goals. It discusses advanced analytical techniques such as PAT, UPLC, and LC-MS, emphasizing their role in ensuring GMP compliance and optimization. The integration of synthetic and biologic methods to streamline the clinical pipeline is analyzed, alongside fostering interdisciplinary collaboration for innovative solutions. Finally,...